Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins

Targeting of MAP kinase pathways by BRAF inhibitors has evolved as a key therapy for BRAF-mutated melanoma. However, it cannot be applied for BRAF-WT melanoma, and also, in BRAF-mutated melanoma, tumor relapse often follows after an initial phase of tumor regression. Inhibition of MAP kinase pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zhe, Gillissen, Bernhard, Richter, Antje, Sinnberg, Tobias, Schlaak, Max S., Eberle, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002974/
https://www.ncbi.nlm.nih.gov/pubmed/36902392
http://dx.doi.org/10.3390/ijms24054961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002974/
https://www.ncbi.nlm.nih.gov/pubmed/36902392
http://dx.doi.org/10.3390/ijms24054961

Ejemplares similares